Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease

Surgical Infections

Volumn 13, Issue 3, 2012, Pages 147-153

  Duane, Therèse M ^a   Weigelt, John A ^b   Puzniak, Laura A ^c   Huang, David B ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CATHETER COMPLICATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STAPHYLOCOCCAL SKIN INFECTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VASCULAR DISEASE;

ACETAMIDES; ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LOWER EXTREMITY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OXAZOLIDINONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN; VASCULAR DISEASES;

EID: 84862884596     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.062     Document Type: Article

References (23)

1. Weigelt JA. Diabetic foot infections: Diagnosis and management. Surg Infect 2010;11:295-298.
2. Lipsky BA, Tabak YP, Johannes RS, et al. Skin and soft tissue infections in hospitalised patients with diabetes: Culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010;53:914-923.
3. Lipsky BA, Itani KM, Weigelt JA, et al. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: Results from three randomized controlled trials. Int J Infect Dis 2011;15:e140-e146.
4. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-551.
5. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: The San Luis Valley Diabetes Study. Circulation 1995;91:1472-1479.
6. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743. (Pubitemid 39056275)
7. Dehghanyar P, Bürger C, Zeitlinger M, et al. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses. Antimicrob Agents Chemother 2005;49:2367-2371. (Pubitemid 40734468)
8. Stein GE, Schooley S, Peloquin CA, et al. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. J Antimicrob Chemother 2007;60:819-823. (Pubitemid 47434261)
9. Weigelt J, Itani K, Stevens D, et al.; Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005;49:2260-2266. (Pubitemid 40734452)
10. Itani KM, Dryden MS, Bhattacharyya H, et al. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg 2010;199:804-816.
11. Gee T, Ellis R, Marshall G, et al. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 2001;45:1843-1846. (Pubitemid 32466358)
12. Stein GE, Wells EM. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: Vancomycin and linezolid. Curr Med Res Opin 2010;26:571-588.
13. Stein GE, Schooley S, Peloquin CA, et al. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. J Antimicrob Chemother 2007;60:819-823. (Pubitemid 47434261)
14. Fry DE, Marek JM, Langsfeld M. Infection in the ischemic lower extremity. Surg Clin North Am 1998;78:465-479. (Pubitemid 28304514)
15. Lipsky BA, Berendt AR, Deery HG, et al.; Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885-910. (Pubitemid 39328144)
16. Cruz CP, Eidt JF, Capps C, et al. Major lower extremity amputations at a Veterans Affairs hospital. Am J Surg 2003;186:449-454. (Pubitemid 37352826)
17. Norgren L, Hiatt WR, Dormandy JA, et al.; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007;26:81-157.
18. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001;15:813-832. (Pubitemid 32852820)
19. Jeffres MN, Isakow W, Doherty JA, et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: Specific evaluation of vancomycin pharmacokinetic indices. Chest 2006;130:947-955. (Pubitemid 44583720)
20. Niederman MS, Wunderink RG, Chastre JE, et al. Outcomes of vancomycin weight-based dosing by trough concentrations for the treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus. Poster presented at the Annual Meeting of the American Thoracic Society. Denver, CO. May 13-18, 2010.
21. Sharpe JN, Shively EH, Polk HC Jr. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg 2005;189:425-428.
22. Lipsky BA, Weigelt JA, Sun X, et al. Risk factors for lower extremity amputation (LEA) among diabetic patients hospitalized for a foot infection. Poster presented at the European Congress of Clinical Microbiology and Infectious Disease. Helsinki, Finland. May 16-19, 2009.
23. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 2010;11:79-109.